Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional survey
van Cutsem, G
MetadataShow full item record
AbstractBackground HIV and TB programs have rapidly scaled-up over the past decade in Sub-Saharan Africa and uninterrupted supplies of those medicines are critical to their success. However, estimates of stock-outs are largely unknown. This survey aimed to estimate the extent of stock-outs of antiretroviral and TB medicines in public health facilities across South Africa, which has the world’s largest antiretroviral treatment (ART) program and a rising multidrug-resistant TB epidemic. Methods We conducted a cross-sectional telephonic survey (October—December 2015) of public health facilities. Facilities were asked about the prevalence of stock-outs on the day of the survey and in the preceding three months, their duration and impact. Results Nationwide, of 3547 eligible health facilities, 79% (2804) could be reached telephonically. 88% (2463) participated and 4% (93) were excluded as they did not provide ART or TB treatment. Of the 2370 included facilities, 20% (485) reported a stock-out of at least 1 ARV and/or TB-related medicine on the day of contact and 36% (864) during the three months prior to contact, ranging from 74% (163/220) of health facilities in Mpumalanga to 12% (32/261) in the Western Cape province. These 864 facilities reported 1475 individual stock-outs, with one to fourteen different medicines out of stock per facility. Information on impact was provided in 98% (1449/1475) of stock-outs: 25% (366) resulted in a high impact outcome, where patients left the facility without medicine or were provided with an incomplete regimen. Of the 757 stock-outs that were resolved 70% (527) lasted longer than one month. Interpretation There was a high prevalence of stock-outs nationwide. Large interprovincial differences in stock-out occurrence, duration, and impact suggest differences in provincial ability to prevent, mitigate and cope within the same framework. End-user monitoring of the supply chain by patients and civil society has the potential to increase transparency and complement public sector monitoring systems.
PublisherPublic Library of Science
- "The number of clients is increasing but the supplies are reducing": provider strategies for responding to chronic antiretroviral (ARV) medicines stock-outs in resource-limited settings: a qualitative study from Uganda.
- Authors: Zakumumpa H, Kiweewa FM, Khuluza F, Kitutu FE
- Issue date: 2019 May 15
- From policy to practice: exploring the implementation of antiretroviral therapy access and retention policies between 2013 and 2016 in six sub-Saharan African countries.
- Authors: Ambia J, Renju J, Wringe A, Todd J, Geubbels E, Nakiyingi-Miiro J, Urassa M, Lutalo T, Crampin AC, Kwaro D, Kyobutungi C, Chimbindi N, Gomez-Olive FX, Tlhajoane M, Njamwea B, Zaba B, Mee P
- Issue date: 2017 Nov 21
- The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe.
- Authors: Chan AK, Ford D, Namata H, Muzambi M, Nkhata MJ, Abongomera G, Mambule I, South A, Revill P, Grundy C, Mabugu T, Chiwaula L, Cataldo F, Hakim J, Seeley J, Kityo C, Reid A, Katabira E, Sodhi S, Gilks CF, Gibb DM, Lablite Team.
- Issue date: 2014 Aug 19
- Inefficient procurement processes undermine access to medicines in the Western Cape Province of South Africa.
- Authors: Magadzire BP, Ward K, Leng HMJ, Sanders D
- Issue date: 2017 Jun 30
- Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study.
- Authors: Naidoo P, Peltzer K, Louw J, Matseke G, McHunu G, Tutshana B
- Issue date: 2013 Apr 26